Recognition and treatment of neonatal jaundice
| Status: |
History |
| Publication date: |
April 2010 |
| Wave: |
14 |
| Process: |
CG |
| Topic area:
|
NICE project team
| Centre for clinical practice lead: |
Christine Carson
|
| Communications manager: |
Laura Gibson
|
| Guidelines commissioning manager: |
Susan Latchem
|
| Guidelines coordinator: |
Elaine Clydesdale
|
| Patient involvement lead: |
Barbara Meredith
|
| Implementation lead: |
Denise Woods
|
| Lead collaborating centre: |
NCC for Women's and Children's Health |
| Guidelines Development Group: |
The Guideline Development Group (GDG) oversees the development process.
|
Email enquiries
Provisional schedule
| Scoping workshop: |
10 January 2008 |
| Consultation on draft scope with stakeholders: |
19 December - 30 January 2008
|
| Consultation on draft guideline with stakeholders: |
27 August - 22 October 2009
|
| Pre-publication check: |
TBC |
| Publication date: |
April 2010 |
Project history
|
19 December 2007
|
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.
|
|
14 February 2008
|
Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.
The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales
|
|
11 June 2008
|
The scope defines what aspects of care are covered by the guideline and to whom it applies.
The Guideline Development Group (GDG) oversees the development process. See below for a list of GDG members.
The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.
Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales above for dates of consultation with stakeholders.
|
|
27 August 2009
|
The consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
|
|
10 February 2010
|
The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
|
|
Key documents
This page was last updated: 21 May 2010
